癲癇外科手術技術專家共識—第一篇：腦內病變相關癲癇_Journal of Epilepsy

Authors：

 中國抗癲癇協會青年委員會 ,  譚啟富癲癇外科發展專項基金管理委員會 ,  北京神經科學學會腦功能疾病與認知發育專業委員會 , 國家兒科及小兒外科專業醫療質量控制中心 , 《癲癇雜志》編輯部

執筆鄺蘇慧（首都醫科大學附屬北京兒童醫院）、劉暢（首都醫科大學附屬北京兒童醫院）、田宏（中日友好醫院）、劉翔宇（南京大學醫學院附屬鼓樓醫院）、梁樹立（首都醫科大學附屬北京兒童醫院）、劉婷紅（首都醫科大學附屬北京兒童醫院）、翟鋒（首都醫科大學附屬北京兒童醫院）、徐金山（首都醫科大學附屬北京兒童醫院）;

Corresponding?author：

中國抗癲癇協會青年委員會, Email: zjguo73@126.com; 譚啟富癲癇外科發展專項基金管理委員會, Email: jiangyuwu@bjmu.edu.cn; 北京神經科學學會腦功能疾病與認知發育專業委員會, Email: 301_1sjwk@sina.cn

Keywords：

DOI：

10.7507/2096-0247.202403003

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 中國抗癲癇協會青年委員會, 譚啟富癲癇外科發展專項基金管理委員會, 北京神經科學學會腦功能疾病與認知發育專業委員會, 國家兒科及小兒外科專業醫療質量控制中心, 《癲癇雜志》編輯部. 癲癇外科手術技術專家共識—第一篇：腦內病變相關癲癇. Journal of Epilepsy, 2024, 10(3): 192-198. doi: 10.7507/2096-0247.202403003 Copy

1.	洪震, 姜玉武, 梁樹立, 等. 臨床診療指南癲癇病分冊, 人民衛生出版社, 2023.
2.	Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia, 2017, 58(4): 512-521.
3.	Blumcke I, Spreafico R, Haaker G, et al. Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery. New England Journal of Medicine, 2017, 377(17): 1648-156.
4.	van Breemen MS, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol, 2007, 6(5): 421-430.
5.	He C, Hu L, Chen C, et al. Clinical characteristics of low‐grade tumor‐related epilepsy and its predictors for surgical outcome. Annals of Clinical and Translational Neurology, 2021, 8(7): 1446-1455.
6.	Liang S, Fan X, Zhao M, et al. Clinical practice guidelines for the diagnosis and treatment of adult diffuse glioma-related epilepsy. Cancer Med, 2019, 8(10): 4527-4535.
7.	Golub VM, Reddy DS. Post-Traumatic Epilepsy and Comorbidities: Advanced Models, Molecular Mechanisms, Biomarkers, and Novel Therapeutic Interventions. Pharmacol Rev, 2022, 74(2): 387-438.
8.	Ding D, Starke RM, Quigg M, et al. Cerebral Arteriovenous Malformations and Epilepsy, Part 1: Predictors of Seizure Presentation. World Neurosurg, 2015, 84(3): 645-652.
9.	Can A, Gross BA, Du R. The natural history of cerebral arteriovenous malformations. Handb Clin Neurol, 2017, 143: 15-24.
10.	Liang S, Fan X, Chen F, et al. Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery. Ther Adv Neurol Disord, 2022, 15: 17562864221114357.
11.	Ding D, Quigg M, Starke RM, et al. Cerebral arteriovenous malformations and epilepsy, part 2: predictors of seizure outcomes following radiosurgery. World Neurosurg. 2015, 84(3): 653-662.
12.	Cossu M, Casaceli G, Gozzo F, et al. Surgical treatment of cavernoma-related epilepsy. J Neurosurg Sci, 2015, 59(3): 112527.
13.	Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia, 2009, 51(6): 1069-1077.
14.	Thijs RD, Surges R, O'Brien TJ, et al. Epilepsy in adults. The Lancet, 2019, 393(10172): 689-701.
15.	Lamberink HJ, Otte WM, Geerts AT, et al. Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis. The Lancet Neurology, 2017, 16(7): 523-531.
16.	Wiebe S, Blume WT, Girvin JP, et al. A rendomzed, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med, 2001, 345(5): 805-811.
17.	Engel J, McDermott MP, Wiebe S, et al. Early surgical therapy for drug-resistant temporal lobe Epilepsy, JAMA, 2012, 309(9): 1153-1160.
18.	Dwivedi R, Ramanujam B, Chandra PS, et al. Surgery for Drug-Resistant Epilepsy in Children. New England Journal of Medicine, 2017, 377(17): 1639-1647.
19.	Englot DJ, Berger MS, Barbaro NM, et al. Factors associated with seizure freedom in the surgical resection of glioneuronal tumors. Epilepsia, 2012, 53(1): 51-57.
20.	Jehi L, Jette N, Kwon CS, et al. Timing of referral to evaluate for epilepsy surgery: Expert Consensus Recommendations from the Surgical Therapies Commission of the International League Against Epilepsy. Epilepsia, 2022, 63(10): 2491-506.
21.	張建國,欒國明. 癲癇外科學(第3版), 人民衛生出版社, 2023.
22.	Lüders HO. Textbook of Epilepsy Surgery. Oxford University Press, 2008.
23.	Lhatoo SD, Kahane P, Lüders HO. Invasive studies of the human epileptic brain. Oxford University Press, 2019.
24.	Steriade C, Martins W, Bulacio J, et al. Localization yield and seizure outcome in patients undergoing bilateral SEEG exploration. Epilepsia, 2018, 60(1): 107-120.
25.	Chassoux F, Landre E, Mellerio C, et al. Dysembryoplastic neuroepithelial tumors: epileptogenicity related to histologic subtypes. Clin Neurophysiol, 2013, 124(6): 1068-1078.
26.	Chassoux F, Rodrigo S, Mellerio C, et al. Dysembryoplastic neuroepithelial tumors: an MRI-based scheme for epilepsy surgery. Neurology, 2012, 79(16): 1699-1707.
27.	Englot DJ, Han SJ, Lawton MT, et al. Predictors of seizure freedom in the surgical treatment of supratentorial cavernous malformations. Journal of Neurosurgery, 2011, 115(6): 1169-1174.
28.	Sevy A, Gavaret M, Trebuchon A, et al. Beyond the lesion: the epileptogenic networks around cavernous angiomas. Epilepsy Res, 2014, 108(4): 701-708.
29.	He X, Zhai F, Guan Y, et al. Surgical outcomes and prognostic factors of drug‐resistant epilepsy secondary to encephalomalacia. Epilepsia, 2019, 60(5): 948-957.
30.	Liu C, Liu Q, Yu H, et al. Surgical treatment in children with intractable epilepsy after viral encephalitis. Epilepsy Research, 2020, 166: 14568.
31.	Bartolomei F, Lagarde S, Wendling F, et al. Defining epileptogenic networks: Contribution of SEEG and signal analysis. Epilepsia, 2017, 58(7): 1131-1147.
32.	Englot DJ, Berger MS, Barbaro NM, et al. Predictors of seizure freedom after resection of supratentorial low-grade gliomas. Journal of Neurosurgery, 2011, 115(2): 240-244.
33.	Still MEH RA, Huberfeld G, Bauchet L, et al. Extent of resection and residual tumor thresholds for postoperative total seizure freedom in epileptic adult patients harboring a supratentorial diffuse low-grade glioma. Neurosurgery, 2018, 85(2): 312-316.
34.	Prada F, Gennari AG, Del Bene M, et al. Intraoperative ultrasonography (ioUS) characteristics of focal cortical dysplasia (FCD) type II b. Seizure, 2019, 69: 80-86.
35.	Raiyani V, Singh S, Sardhara J, et al. Seizure outcome after lesionectomy with or without concomitant anteromedial temporal lobectomy for low-grade gliomas of the medial temporal lobe. Asian Journal of Neurosurgery, 2022, 16(3): 518-524.
36.	Cataltepe OTG, Yalnizoglu D, Top?u M, et al. Surgical management of temporal lobe tumor-related epilepsy in children. J Neurosurg(Pediatrics), 2005, 102: 11152.
37.	Giulioni M, Rubboli G, Marucci G, et al. Seizure outcome of epilepsy surgery in focal epilepsies associated with temporomesial glioneuronal tumors: lesionectomy compared with tailored resection. J Neurosurg, 2009, 111(6): 1275-1282.
38.	Tebo CC, Evins AI, Christos PJ, et al. Evolution of cranial epilepsy surgery complication rates: a 32-year systematic review and meta-analysis. Journal of Neurosurgery, 2014, 120(6): 1415-1427.

1. 洪震, 姜玉武, 梁樹立, 等. 臨床診療指南癲癇病分冊, 人民衛生出版社, 2023.
2. Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia, 2017, 58(4): 512-521.
3. Blumcke I, Spreafico R, Haaker G, et al. Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery. New England Journal of Medicine, 2017, 377(17): 1648-156.
4. van Breemen MS, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol, 2007, 6(5): 421-430.
5. He C, Hu L, Chen C, et al. Clinical characteristics of low‐grade tumor‐related epilepsy and its predictors for surgical outcome. Annals of Clinical and Translational Neurology, 2021, 8(7): 1446-1455.
6. Liang S, Fan X, Zhao M, et al. Clinical practice guidelines for the diagnosis and treatment of adult diffuse glioma-related epilepsy. Cancer Med, 2019, 8(10): 4527-4535.
7. Golub VM, Reddy DS. Post-Traumatic Epilepsy and Comorbidities: Advanced Models, Molecular Mechanisms, Biomarkers, and Novel Therapeutic Interventions. Pharmacol Rev, 2022, 74(2): 387-438.
8. Ding D, Starke RM, Quigg M, et al. Cerebral Arteriovenous Malformations and Epilepsy, Part 1: Predictors of Seizure Presentation. World Neurosurg, 2015, 84(3): 645-652.
9. Can A, Gross BA, Du R. The natural history of cerebral arteriovenous malformations. Handb Clin Neurol, 2017, 143: 15-24.
10. Liang S, Fan X, Chen F, et al. Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery. Ther Adv Neurol Disord, 2022, 15: 17562864221114357.
11. Ding D, Quigg M, Starke RM, et al. Cerebral arteriovenous malformations and epilepsy, part 2: predictors of seizure outcomes following radiosurgery. World Neurosurg. 2015, 84(3): 653-662.
12. Cossu M, Casaceli G, Gozzo F, et al. Surgical treatment of cavernoma-related epilepsy. J Neurosurg Sci, 2015, 59(3): 112527.
13. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia, 2009, 51(6): 1069-1077.
14. Thijs RD, Surges R, O'Brien TJ, et al. Epilepsy in adults. The Lancet, 2019, 393(10172): 689-701.
15. Lamberink HJ, Otte WM, Geerts AT, et al. Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis. The Lancet Neurology, 2017, 16(7): 523-531.
16. Wiebe S, Blume WT, Girvin JP, et al. A rendomzed, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med, 2001, 345(5): 805-811.
17. Engel J, McDermott MP, Wiebe S, et al. Early surgical therapy for drug-resistant temporal lobe Epilepsy, JAMA, 2012, 309(9): 1153-1160.
18. Dwivedi R, Ramanujam B, Chandra PS, et al. Surgery for Drug-Resistant Epilepsy in Children. New England Journal of Medicine, 2017, 377(17): 1639-1647.
19. Englot DJ, Berger MS, Barbaro NM, et al. Factors associated with seizure freedom in the surgical resection of glioneuronal tumors. Epilepsia, 2012, 53(1): 51-57.
20. Jehi L, Jette N, Kwon CS, et al. Timing of referral to evaluate for epilepsy surgery: Expert Consensus Recommendations from the Surgical Therapies Commission of the International League Against Epilepsy. Epilepsia, 2022, 63(10): 2491-506.
21. 張建國,欒國明. 癲癇外科學(第3版), 人民衛生出版社, 2023.
22. Lüders HO. Textbook of Epilepsy Surgery. Oxford University Press, 2008.
23. Lhatoo SD, Kahane P, Lüders HO. Invasive studies of the human epileptic brain. Oxford University Press, 2019.
24. Steriade C, Martins W, Bulacio J, et al. Localization yield and seizure outcome in patients undergoing bilateral SEEG exploration. Epilepsia, 2018, 60(1): 107-120.
25. Chassoux F, Landre E, Mellerio C, et al. Dysembryoplastic neuroepithelial tumors: epileptogenicity related to histologic subtypes. Clin Neurophysiol, 2013, 124(6): 1068-1078.
26. Chassoux F, Rodrigo S, Mellerio C, et al. Dysembryoplastic neuroepithelial tumors: an MRI-based scheme for epilepsy surgery. Neurology, 2012, 79(16): 1699-1707.
27. Englot DJ, Han SJ, Lawton MT, et al. Predictors of seizure freedom in the surgical treatment of supratentorial cavernous malformations. Journal of Neurosurgery, 2011, 115(6): 1169-1174.
28. Sevy A, Gavaret M, Trebuchon A, et al. Beyond the lesion: the epileptogenic networks around cavernous angiomas. Epilepsy Res, 2014, 108(4): 701-708.
29. He X, Zhai F, Guan Y, et al. Surgical outcomes and prognostic factors of drug‐resistant epilepsy secondary to encephalomalacia. Epilepsia, 2019, 60(5): 948-957.
30. Liu C, Liu Q, Yu H, et al. Surgical treatment in children with intractable epilepsy after viral encephalitis. Epilepsy Research, 2020, 166: 14568.
31. Bartolomei F, Lagarde S, Wendling F, et al. Defining epileptogenic networks: Contribution of SEEG and signal analysis. Epilepsia, 2017, 58(7): 1131-1147.
32. Englot DJ, Berger MS, Barbaro NM, et al. Predictors of seizure freedom after resection of supratentorial low-grade gliomas. Journal of Neurosurgery, 2011, 115(2): 240-244.
33. Still MEH RA, Huberfeld G, Bauchet L, et al. Extent of resection and residual tumor thresholds for postoperative total seizure freedom in epileptic adult patients harboring a supratentorial diffuse low-grade glioma. Neurosurgery, 2018, 85(2): 312-316.
34. Prada F, Gennari AG, Del Bene M, et al. Intraoperative ultrasonography (ioUS) characteristics of focal cortical dysplasia (FCD) type II b. Seizure, 2019, 69: 80-86.
35. Raiyani V, Singh S, Sardhara J, et al. Seizure outcome after lesionectomy with or without concomitant anteromedial temporal lobectomy for low-grade gliomas of the medial temporal lobe. Asian Journal of Neurosurgery, 2022, 16(3): 518-524.
36. Cataltepe OTG, Yalnizoglu D, Top?u M, et al. Surgical management of temporal lobe tumor-related epilepsy in children. J Neurosurg(Pediatrics), 2005, 102: 11152.
37. Giulioni M, Rubboli G, Marucci G, et al. Seizure outcome of epilepsy surgery in focal epilepsies associated with temporomesial glioneuronal tumors: lesionectomy compared with tailored resection. J Neurosurg, 2009, 111(6): 1275-1282.
38. Tebo CC, Evins AI, Christos PJ, et al. Evolution of cranial epilepsy surgery complication rates: a 32-year systematic review and meta-analysis. Journal of Neurosurgery, 2014, 120(6): 1415-1427.

Previous Article
癲癇外科手術技術專家共識—概述與編寫方法
Next Article
癲癇外科手術技術專家共識—第二篇：腦皮質發育不良相關癲癇

Journal of Epilepsy

癲癇外科手術技術專家共識—第一篇：腦內病變相關癲癇

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content